Plain-English translation of NCT03378739 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a registry study — a research database — that collects information from adults who receive treatment for cardiogenic shock (a life-threatening condition where the heart suddenly cannot pump blood effectively). Researchers will gather details about your treatment and outcomes to understand which approaches work best and how to improve care quality at Inova Heart and Vascular Institute.
When the heart fails suddenly, doctors need to act fast with specialized treatment. This study exists to learn which treatments and protocols are most effective, identify which patients are at highest risk for complications, and continuously improve the quality of care for this serious condition.
You likely qualify if…
You likely don't qualify if…
You do not need to do anything special — researchers will simply collect information from your medical records during your treatment at Inova Heart and Vascular Institute. This includes details about your hospital stay, the procedures you receive, and your health outcomes. There are no additional visits or tests required beyond your regular care.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
United States
Enrollment target
~3,000 participants
Started
January 2018
Primary completion
December 2099
Age range
18 Years – 85 Years
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Bhruga Shah
Inova Health Care Services
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.